ArticleeLife2023

Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma.

He Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.